Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis
Пресепсин для диагностики раннего неонатального сепсиса: систематический обзор и мета-анализ
Poggi C, Lucenteforte E, Petri D, De Masi S, Dani C.Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022 May 31. doi: 10.1001/jamapediatrics.2022.1647
Presepsin: Hope in the Quest for the Holy Grail
Abhishek Samprathi1, Madhusudan Samprathi2, Mounika Reddy31 Department of Critical Care Medicine, Fortis Hospitals, Bengaluru, Karnataka, India
2,3 Department of Pediatrics, All India Institute of Medical Sciences, Hyderabad, Telangana, India
Corresponding Author: Madhusudan Samprathi, Department of Pediatrics, All India Institute of Medical Sciences, Hyderabad, Telangana, India, Phone: +917077703235, e-mail: madhu_1511@yahoo.com
Perinatal presepsin assessment: a new sepsis diagnostic tool?
Valentina Botondi, Ebe D’Adamo, Mario Plebani, Oriana Trubiani, Marika Perrotta, Laura Di Ricco, Cynzia Spagnuolo, Sara De Sanctis, Elisabetta Barbante, Maria Chiara Strozzi, Antonio Maconi, Francesca Gazzolo, Marta Betti, Annalisa Roveta, Gabriella Levantini and Diego Gazzolo*Valentina Botondi, Ebe D’Adamo, Marika Perrotta, Laura Di Ricco, Cynzia Spagnuolo, Sara De Sanctis, Elisabetta Barbante and Gabriella Levantini, Neonatal Intensive Care Unit, G. D’Annunzio University, Chieti, Italy
Mario Plebani, Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy. https://orcid.org/0000-0002-0270-1711
Oriana Trubiani, Department of Innovative Technologies in Medicine & Dentistry, University “G. D’Annunzio”, Chieti, Italy
Maria Chiara Strozzi, Antonio Maconi, Marta Betti and Annalisa Roveta, AO SS Antonio, Biagio and C. Arrigo Hospital, Alessandria, Italy. https://orcid.org/0000-0002-1904-7277 (A. Roveta)
Francesca Gazzolo, Magna Graecia University, Catanzaro, Italy
*Corresponding author: Prof. Diego Gazzolo, Neonatal Intensive Care Unit, G. D’Annunzio University, 65100 Chieti, Italy, Phone: +39 0871 358219, E-mail: dgazzolo@hotmail.com
Пресепсин в диагностике нозокомиальной инфекции центральной нервной системы
С.А. Абудеев1, К.В. Киселев2, О.В. Паринов1, Ю.Д. Удалов1, М.В. Забелин1, А.С. Самойлов1, К.А. Попугаев1*Отделение нейрореанимации и нейроанестезиологии
1 ФГБУ «ГНЦ — ФМБЦ имени А.И. Бурназяна» ФМБА,
Российская Федерация, 123098 Москва, ул. Маршала Новикова, д. 23
2 ГБОУ ВО «РНИМУ имени Н.И. Пирогова» Минздрава России, Российская Федерация, 117997 Москва, ул. Островитянова, д. 1
* Контактная информация: Попугаев Константин Александрович, доктор медицинских наук, заведующий отделением нейрореанимации ФГБУ ГНЦ ФМБЦ А.И. Бурназяна ФМБА России. E-mail: stan.popugaev@yahoo.com
Biomarkers of Neonatal Sepsis: From Being Mere Numbers to Becoming Guiding Diagnostics
Sai Sravya Gude 1, Nikhil Chowdary Peddi 2, Sravya Vuppalapati 2, Shravya Venu Gopal 3, Harshita Marasandra Ramesh 4, Sai Sreeya Gude 51 Pediatrics, Guntur Medical College, Guntur, IND
2 Pediatrics, PES Institute of Medical Sciences and Research, Kuppam,IND
3 InternalMedicine,KasturbaMedicalCollegeMangalore,Mangalore,IND
4 InternalMedicineand Pediatrics, Kasturba Medical College Mangalore, Mangalore, IND
5 Internal Medicine, Guntur Medical College, Guntur, IND
Corresponding author: Nikhil Chowdary Peddi, nikhilchowdarypeddi@gmail.com
Биомаркеры инфекции в оптимизации антибактериальной терапии: оправданные ожидания
Кулабухов В.В.1, Шабанов А.К.1, Андреева И.В.2, Стецюк О.У.2, Андреев В.А.31 НИИ скорой помощи им. Н.В. Склифосовского, Москва, Россия
2 НИИ антимикробной химиотерапии ФГБОУ ВО СГМУ Минздрава России, Смоленск, Россия
3 ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России, Смоленск, Россия
Контактный адрес: Ирина Вениаминовна Андреева, E-mail: Irina.Andreeva@antibiotic.ru
The Emerging Role of Presepsin (P-SEP) in the Diagnosis of Sepsis in the Critically Ill Infant: A Literature Review
Chiara Maddaloni 1, Domenico Umberto De Rose 1 , Alessandra Santisi 1, Ludovica Martini 1, Stefano Caoci 1, Iliana Bersani 1, Maria Paola Ronchetti 1,2 and Cinzia Auriti 1,*,†1 Neonatal Intensive Care Unit (NICU), Medical and Surgical Department of the Fetus—Newborn-Infant, “Bambino Gesù” Children’s Hospital IRCCS, 00165 Rome, Italy; chiara.maddaloni@opbg.net (C.M.); domenico.derose@opbg.net (D.U.D.R.); alessandra.santisi@opbg.net (A.S.); ludovica.martini@opbg.net (L.M.); stefano.caoci@opbg.net (S.C.); iliana.bersani@opbg.net (I.B.); mariapaola.ronchetti@opbg.net (M.P.R.)
2 Neonatal Intensive Care (NICU) and Neonatal Pathology, San Vincenzo Hospital, 98039 Taormina, Italy
Correspondence: cinzia.auriti@opbg.net; Tel.: +39-06-6859-2427; Fax: +39-06-6859-3916
† On behalf of the Study Group of Neonatal Infectious Diseases of the Italian Society of Neonatology (SIN)
Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review
Andrea Piccioni1, Michele Cosimo Santoro1,*, Tommaso de Cunzo2 et al.1 Emergency Medicine Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy;
andrea.piccioni@policlinicogemelli.it (A.P.); sara.cicchinelli@policlinicogemelli.it (S.C.); marcomaria.pascale@policlinicogemelli.it (M.M.P.); marcello.candelli@policlinicogemelli.it (M.C.); marcello.covino@policlinicogemelli.it (M.C.); francesco.franceschi@policlinicogemelli.it (F.F.)
2 Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy;
tomdecunzo@gmail.com (T.d.C.); gianlucatullo@gmail.com (G.T.); saviange@libero.it (A.S.); fede.valletta@gemelli.com (F.V.)
* Correspondence: michelecosimo.santoro@policlinicogemelli.it
Presepsin as a Predictive Biomarker of Severity in COVID-19: A Systematic Review
Sibtain Ahmed1, Maheen Mansoor2, Muhammad S Shaikh3, Imran Siddiqui41,3,4 Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan
2 Department of Medical College, Aga Khan University, Karachi, Pakistan
Corresponding Author: Sibtain Ahmed, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan, e-mail: sibtain.ahmed@aku.edu
The Role and Validity of Diagnostic Biomarkers in Late-Onset Neonatal Sepsis
Patience Mwesigye1, Fizza Rizwan2, Niazy Alassaf3, Rizwan Khan31 InternalMedicine,UniversityofLimerick,Limerick,IRL
2 InternalMedicine,MedicalUniversityofSofia,Sofia,BGR
3 Neonatology, University Maternity Hospital, Limerick, Limerick, IRL
Corresponding author: Patience Mwesigye, patiencehonors@gmail.com
Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review
Andrea Piccioni1, Michele Cosimo Santoro1,*, Tommaso de Cunzo2, Gianluca Tullo2, Sara Cicchinelli1, Angela Saviano2, Federico Valletta2, Marco Maria Pascale1, Marcello Candelli1, Marcello Covino1,2 and Francesco Franceschi1,21 Emergency Medicine Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy; andrea.piccioni@policlinicogemelli.it (A.P.); sara.cicchinelli@policlinicogemelli.it (S.C.);
marcomaria.pascale@policlinicogemelli.it (M.M.P.); marcello.candelli@policlinicogemelli.it (M.C.);
marcello.covino@policlinicogemelli.it (M.C.); francesco.franceschi@policlinicogemelli.it (F.F.)
2 Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; tomdecunzo@gmail.com (T.d.C.); gianlucatullo@gmail.com (G.T.); saviange@libero.it (A.S.); fede.valletta@gemelli.com (F.V.)
*Correspondence: michelecosimo.santoro@policlinicogemelli.it
Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis
Dimitrios Velissaris1, Nicholas Zareifopoulos2, 3, Vasileios Karamouzos4, Evangelos Karanikolas5, Charalampos Pierrakos6, Ioanna Koniari7, Menelaos Karanikolas82 Department of Psychiatry, General Hospital of Nikaia, Piraeus "Agios Panteleimon", Athens, GRC 3Department of Internal Medicine, University of Patras School of Health Sciences, Patras, GRC
4 Intensive Care Unit, General University Hospital of Patras, Patras, GRC
5 Department of Internal Medicine, University of Patras, Patras, GRC
6 Intensive Care Unit, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, BEL
7 Department of Electrophysiology and Device, University Hospital of South Manchester NHS Foundation Trust, Manchester, GBR
8 Department of Anesthesiology, Washington University School of Medicine, St. Louis, USA
Corresponding author: Nicholas Zareifopoulos, nizareifopoulos@gmail.com
Novel Diagnostics and Therapeutics in Sepsis
Kieran Leong 1, Bhavita Gaglani 2 , Ashish K. Khanna 2,3, Michael T. McCurdy 1,*1 Division of Pulmonary & Critical Care, University of Maryland School of Medicine, Baltimore, MD 21201, USA; kleong@som.umaryland.edu
2 Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest University Hospital, Winston-Salem, NC 27157, USA; bgaglani@wakehealth.edu (B.G.); ashish@or.org (A.K.K.)
3 Department of Outcomes Research, Outcomes Research Consortium, Cleveland, OH 44195, USA
* Correspondence: drmccurdy@gmail.com
Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C‑reactive protein: a systematic review and meta‑analysis
Chin‑Chieh Wu1, Hao‑Min Lan2, Shih‑Tsung Han3, Chung‑Hsien Chaou3, Chun‑Fu Yeh4, Su‑Hsun Liu2,5,6 Clinical Informatics and Medical Statistics Research Center, Chang Gung
University, 5 Fu‑Shin Street, Gueishan Village, Taoyuan 333, Taiwan
Full list of author information is available at the end of the article
Presepsin as a Potential Prognostic Marker for Sepsis According to Actual Practice Guidelines
Alice Nicoleta Dragoescu 1, Vlad Padureanu 2,* , Andreea Doriana Stanculescu 1,*, Luminit,a Cristina Chiut,u 1,Dan Nicolae Florescu 3, Ioana Andreea Gheonea 4, Rodica Padureanu 5 , Alex Stepan 6, Costin Teodor Streba 7,
Andrei Ioan Drocas,
8, Adriana Mihaela Ciocâlteu-Ionescu 3, Valeriu MarinS,
urlin 9 and Octavian
Craiova, Romania; alice.dragoescu@yahoo.com (A.N.D.); luminita.chiutu@gmail.com (L.C.C.)
2 Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
3 Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
nicku_dan@yahoo.co.uk (D.N.F.); adriana_ciocalteu@yahoo.com (A.M.C.-I.)
4 Department of Radiology and Medical Imaging, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; iagheonea@gmail.com
5 Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
zegheanurodica@yahoo.com
6 Department of Pathology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
astepan76@yahoo.com
7 Department of Research Methodology, University of Medicine and Pharmacy of Craiova, 200349 Craiova,
Romania; costinstreba@gmail.com
8 Department of Urology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania;
andrei_drocas@yahoo.com (A.I.D.); pdragoescu@yahoo.com (O.P.D.)
9 Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
vsurlin@gmail.com
* Correspondence: vldpadureanu@yahoo.com (V.P.); stanculescu.andreea@yahoo.com (A.D.S.)
Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis
this work.
6Division of Trauma and Surgical Critical Care, Osaka General Medical Center,
3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan
Full list of author information is available at the end of the article
Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C‑reactive protein: a systematic review and meta‑analysis
Chin‑Chieh Wu1, Hao‑Min Lan2, Shih‑Tsung Han3, Chung‑Hsien Chaou3, Chun‑Fu Yeh4, Su‑Hsun Liu2,5,6 Clinical Informatics and Medical Statistics Research Center, Chang Gung
University, 5 Fu‑Shin Street, Gueishan Village, Taoyuan 333, Taiwan
Full list of author information is available at the end of the article
The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis
Ying Zhu1,2Xuehui Li1
Peiyan Guo1
Yuhan Chen3
Jiandong Li1
The Seventh Medical Center of PLA
General Hospital, Beijing, People’s
Republic of China; 2Department of
Respiratory and Critical Care Medicine,
Shanghai East Hospital, Tongji University,
Shanghai, People’s Republic of China;
3Affiliated BaYi Children’s Hospital, The
Seventh Medical Center of PLA General
Hospital, Beijing, People’s Republic of
China; 4Department of Anesthesiology,
Air Force Medical Center, PLA, Beijing,
People’s Republic of China
Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
Presepsin as a biomarker in perioperative medicine
Jessica HANDKE 1, Ornella PIAZZA 2 *, Jan LARMANN 1,Simonetta TESORO 3, Edoardo DE ROBERTIS 3
University of Perugia, Perugia, Italy
Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis
1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
Presepsin as a New Marker for Early Detection Neonatal Sepsis in Al-Quwayiyah General Hospital Riyadh, KSA
2Microbiology Laboratory, Al-Quwayiyah General Hospital, Riyadh, KSA.
3Department of Pediatrics, Faculty of Medicine, Benha University, Egypt.
4Nursery Department, Al-Quwayiyah General Hospital, Riyadh, KSA.а
The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review
Lin Ruan1*, Guan-Yu Chen1, Zhen Liu1,2†, Yun Zhao1,2†, Guang-Yu Xu1,2†, Shu-Fang Li1,2†, Chun-Ni Li1,2†,Lin-Shan Chen1,3† and Zheng Tao1,3†
Роль биохимических маркеров воспаления у пациентов с нейтропенией после химиотерапии
Ю.Н. Дубинина1, В.О. Саржевский2, В.Я. Мельниченко2
1 Клиника амбулаторной онкологии и гематологии, ул. Молодогвардейская, д. 2, корп. 1, Москва, Российская Федерация, 121467
2 ФГБУ «Национальный медико-хирургический центр им. Н.И. Пиро-
гова», Минздрава России, ул. Нижняя Первомайская, д. 70, Москва,
Российская Федерация, 105203
Sepsis diagnosis and monitoring – procalcitonin as standard, but what next?
Magdalena Mierzchała-Pasierb, Department of MedicalBiochemistry, Wroclaw Medical University,
10 Chalubinskiego St., 50-368 Wroclaw, Poland,
e-mail: magdalena.mierzchala-pasierb@umed.wroc.pl
Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis
Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1
1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis
Ying Zhu1,2Xuehui Li1
Peiyan Guo1
Yuhan Chen3
Jiandong Li1
The Seventh Medical Center of PLA
General Hospital, Beijing, People’s
Shanghai, People’s Republic of China;
3Affiliated BaYi Children’s Hospital, The
Seventh Medical Center of PLA General
Hospital, Beijing, People’s Republic ofChina;
People’s Republic of China
Diagnostic Value and Prognostic Use of Presepsin Versus Procalcitonin in Sepsis
Deepak P. Venugopalan , Gopalakrishna Pillai , Sajitha Krishnan1. Internal Medicine, Aster Medcity, Kochi, IND 2. Internal Medicine, Amrita Institute of Medical
Sciences and Research Centre, Kochi, IND
Corresponding author: Deepak P. Venugopalan, drdeepakvenugopalan@gmail.com
Disclosures can be found in Additional Information at the end of the article
Can presepsin be used for screening invasive fungal infections?
Giuseppe Lippi 1 , Gianfranco Cervellin 21 Section of Clinical Biochemistry, University of Verona, Verona, Italy; 2 Emergency Department, University Hospital of Parma, Parma, Italy
Correspondence to: Prof. Giuseppe Lippi. Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37134 Verona, Italy.
Email: giuseppe.lippi@univr.it
The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review
Lin Ruan 1* , Guan-Yu Chen 1 , Zhen Liu 1,2† , Yun Zhao 1,2† , Guang-Yu Xu 1,2† , Shu-Fang Li 1,2† , Chun-Ni Li 1,2† , Lin-Shan Chen 1,3† and Zheng Tao 1,3†† Zhen Liu, Yun Zhao, Guang-Yu Xu, Shu-Fang Li, Chun-Ni Li, Lin-Shan Chen and Zheng Tao contributed equally to this work.
1 Departments of Anesthesiology, Guangxi Medical University Affiliated Tumor Hospital, Naning, Guangxi, China
Full list of author information is available at the end of the article
Prognostic value of presepsin in adult patients with sepsis: Systematic review and metaanalysis
Hyun Suk Yang1, Mina Hur2*, Ahram Yi2, Hanah Kim2, Seungho Lee3, Soo-Nyung Kim41 Department of Cardiovascular Medicine, Research Institute of Medical Science, Konkuk University School
of Medicine, Seoul, Korea, 2 Department of Laboratory Medicine, Konkuk University School of Medicine,
Seoul, Korea, 3 School of Public Health, Seoul National University, Seoul, Korea, 4 Department of Obstetrics
and Gynecology, Konkuk University School of Medicine, Seoul, Korea
* dearmina@hanmail.net
The role of presepsin, c-reactive protein and procalcitonin as a marker of therapy response and prognosis for late onset neonatal sepsis in preterm neonates
Dalima AW Astrawinata 1 , Risma Kerina Kaban 2 , Rosalina Dewi Roeslani 3 , Erna Parmawati 41 Department of Clinical Pathology, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
2 Department of Pediatric, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
3 Department of Pediatric, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
4 Department of Clinical Pathology Medical Specialty Program, Faculty of Medicine University Indonesia/Dr.Cipto
Mangunkusumo National General Hospital, Jakarta.
Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta‐analysis
В статье приводится таблица разлиных маркеров сепсиса, их чувствительность и специфичность.Yong Liu 1† , Jun‐huan Hou 2,3† , Qing Li 2,3 , Kui‐jun Chen 2,3 , Shu‐Nan Wang 4 and Jian‐min Wang 2,3*
† Yong Liu and Jun-huan Hou contributed equally to this work
2 Research Institute of Surgery, Daping Hospital, Third Military Medical
University, Chongqing 400042, People’s Republic of China
Full list of author information is available at the end of the article
Новый высокочувствительный и высокоспецифичный маркер неонатального сепсиса - пресепсин
Д.Ж. БАТЫРБАЕВА, Б.А. РАМАЗАНОВА, А. БЕКНАЗАРОВА, Ж.С. АЛИБАЕВА, А.А. АБДРАИМОВАА.Д. НУРАХОВА, Н.К. ИБРАЕВА, Р.С. БАТЫРХАНОВА
Казахский Национальный медицинский университет им. С.Д. Асфендиярова, НИИ ПФМ им. Б.А. Атшабарова,
Научная клинико-диагностическая лаборатория
Биологические маркеры в диагностике и лечении сепсиса (обзор литературы)
А. А. Звягин, В. С. Демидова, Г. В. СмирновФГБУ «Институт хирургии им. А. В. Вишневского» Минздрава России; Россия, 117997, Москва, ул. Большая Серпуховская, 27
Контакты: Альфред Аркадьевич Звягин zvyagin@ixv.ru
Diagnostic and Prognostic Value of Presepsin for Subclinical Chorioamnionitis in Pregnancies between 23-28 Week with Preterm Premature Rupture of the Membranes
Erbil Çakar¹, Şule Eren Çakar², Habibe Ayvacı Taşan¹, Deniz Karçaaltıncaba³, Mehmet Baki Şentürk¹,Nermin Koç4, Ramazan Uluhan5
¹Department of Obstetrics and Gynecology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
²Deparment of Infectious Diseases, Ümraniye Training and Research Hospital, İstanbul, Turkey
³Department of Obstetrics and Gynecology, Gazi University School of Medicine, Ankara, Turkey
4Department of Pathology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
5Department of Clinical Microbiology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
Пресепсин – ранний и надежный диагностический и прогностический маркер неонатального сепсиса
Jehan H Sabry1, Osama A Elfeky2, Akram E Elsadek3, Ahmed A Eldaly4.1. Assistant Professor of Clinical & Chemical Pathology, Benha Faculty of Medicine, Egypt.
2. Professor of Pediatrics, Benha Faculty of Medicine, Egypt.
3. Lecturer of Pediatric, Benha Faculty of Medicine, Egypt.
4. Resident of Pediatrics, Ministry of Health, Egypt.
Presepsin as an important diagnostic biomarker that differentiates sepsis from non-infectious SIRS in critical ill adult patients: A system review and meta-analysis
Dan Xie1 †, Kunpeng Hu2 †, Purun Lei3, Ying Xian1, Ying Wang1, Xiaogang Bi1, Kouxing Zhang1**Correspondence: Professor Kouxing Zhang, Department of General ICU of Lingnan Hospital, The Third Affiliated Hospital, Sun Yat-sen
University, Guangzhou, China,
Перспективы применения новых лабораторных методов в ранней диагностике сепсиса
Годило-Годлевский В.А., полковник вн. сл. в отставке, заместитель главного врача Медико-реабилитационного центра «Здоровье для вас», доцент кафедры факультативной терапии и пропедевтики внутренних болезней Государственной классической академии им. Маймонида, д.м.н., vg-god@rambler.ruГурбатова Т.Ю., начальник лабораторного отделения Главного клинического госпиталя МВД России;
Мельникова С.В., подполковник вн. сл., заместитель начальника лабораторного отделения – врач клинической лабораторной диагностики Главного клинического госпиталя МВД России, к.б.н.
Presepsin: A Novel and Potential Diagnostic Biomarker for Sepsis
K V Ramana1,*, Venkata BharatKumar Pinnelli2, Sabitha Kandi3, Asha G2, Jayashankar CA4, Bhanuprakash5, Raghavendra DS2, Sanjeev D rao11Department of Microbiology, Prathima Institute of Medical sciences, Karimnagar, India 2Department of Biochemistry, Vydehi Institute of Medical sciences and Research center, Bengaluru, India 3Department of Biochemistry, Chalmeda Anandarao Institute of Medical sciences, Karimnagar, India 4Department of General Medicine, Vydehi Institute of Medical sciences and Research center, Bengaluru, India 5Department of Dermatology, Vydehi Institute of Medical sciences and Research center, Bengaluru, India
*Corresponding author: ramana_20021@rediffmail.com